Radiation-induced increase in plasma Flt3 ligand concentration in mice: Evidence for the implication of several cell types

Radiation Research

Volumn 163, Issue 4, 2005, Pages 408-417

  Prat, Marie ^a,b   Demarquay, Christelle ^a,b   Frick, Johanna ^a,b   Thierry, Dominique ^a,b   Gorin, Norbert Claude ^b,c   Bertho, Jean Marc ^a,b  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW APLASIA; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION RESPONSE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; X IRRADIATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, RADIATION; MALE; MEMBRANE PROTEINS; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED BALB C; ORGAN SPECIFICITY; RADIATION DOSAGE; RADIATION INJURIES; RED-CELL APLASIA, PURE; TISSUE DISTRIBUTION; WHOLE-BODY IRRADIATION;

EID: 15544365712     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3340     Document Type: Article

References (36)

1. S. D. Lyman, L. James, T. Vanden Bos, P. de Vries, K. Brasel, B. Gliniak, L. T. Hollingworth, K. S. Picha, H. J. McKenna and P. Beckmann, Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells. Cell 75, 1157-1167 (1993).
2. S. D. Lyman, L. James, L. Johnson, K. Brasel, P. de Vries, S. S. Escobar, H. Downey, R. R. Splett, M. P. Beckmann and H. J. McKenna, Cloning of the human homologue of the murine Flt3 ligand: A growth factor for early hematopoietic progenitor cells. Blood 83, 2795-2801 (1994).
3. M. Lisovsky, S. E. Braun, Y. Ge, H. Takahira, L. Lu, V. G. Savchenko, S. D. Lyman and H. E. Broxmeyer, Flt3 ligand production by human bone marrow stromal cells. Leukemia 10, 1012-1020 (1996).
4. A. Solanilla, C. Grosset, C. Lemercier, M. Dupouy, F. X. Mahon, K. Schweiter, J. Reiffers, B. Weksler and J. Ripoche, Expression of Flt-3 ligand by the endothelial cell. Leukemia 14, 153-162 (2000).
5. E. Chklovskaia, W. Jansen, C. Nissen, S. D. Lyman, C. Rahner, L. Landmann and A. Wodnar-Filipowicz, Mechanism of Flt3 ligand expression in bone marrow failure: Translocation from intracellular stores to the surface of T lymphocytes after chemotherapy-induced suppression of hematopoiesis. Blood 93, 2595-2604 (1999).
6. C. Hannum, J. Culpepper, D. Campbell, T. McClanahan, S. Zurawski, J. F. Bazan, R. Kastelein, S. Hudak, J. Wagner and F. Lee, Ligand for Flt3/Flk2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNA. Nature 368, 643-648 (1994).
7. B. E. Hunte, S. Hudak, D. Campbell, Y. Xu and D. Rennick, Flk2/Flt3 ligand is a potent co factor for the growth of primitive B cell progenitors. J. Immunol. 156, 489-496 (1995).
8. J. M. Bertho, A. Chapel, S. Loilleux, J. Frick, J. Aigueperse, N. C. Gorin and P. Gourmelon, CD135 (Flk2/Flt3) expression by human thymocytes delineates a possible role of Flt3 ligand in T cell precursor proliferation and differentiation. Scand. J. Immunol. 52, 53-61 (2000).
9. R. Ray, C. Paige, C. Furlonger, S. Lyman and R. Rottapel, Flt3 ligand supports the differentiation of early B cell progenitors in the presence of interleukin-11 and interleukin-7. Eur. J. Immunol. 26, 1504-1510 (1996).
10. + pro-B cells. Blood 90, 4321-4331 (1997).
11. E. Maraskovsky, E. Daro, E. Roux, M. Teepe, C. R. Maliszewski, J. Hoek, D. Caron, M. E. Lebsack and H. J. McKenna, In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 96, 878-884 (2000).
12. + lymphoid-related dendritic cells. J. Immunol. 165, 795-803 (2000).
13. E. Sitnicka, D. Bryder, K. Theilgaard-Mönch, N. Buza-Vidas, J. Adolfsson and S. E. Jacobsen, Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity 17, 463-472 (2002).
14. T. J. Fry, M. Sinha, M. Milliron, Y. W. Chu, V. Kapoor, R. E. Gress, E. Thomas and C. L. Mackall, Flt3 ligand enhances thymic-dependent and thymic independent immune reconstitution. Blood 104, 2794-2800 (2004).
15. S. D. Lyman, M. Seaberg, R. Hanna, J. Zappone, K. Brasel, J. L. Abkowitz, J. I. Prchal, J. C. Schultz and N. T. Shahidi, Plasma/serum levels of Flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia. Blood 86, 4091-4096 (1995).
16. A. Wodnar-Filipowicz, S. D. Lyman, A. Gratwohl, A. Tichelli, B. Speck and C. Nissen, Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia. Blood 88, 4493-4499 (1996).
17. J. M. Bertho, C. Demarquay, J. Frick, C. Joubert, S. Arenales, N. Jacquet, I. Sorokine-Durm, Q. Chau, M. Lopez and P. Gourmelon, Level of Flt3 ligand in plasma: A possible new bio-indicator for radiation-induced aplasia. Int. J. Radiat. Biol. 77, 703-712 (2001).
18. A. Huchet, Y. Belkacemi, J. Frick, M. Prat, I. Muresan-Kloos, D. Altan, A. Chapel, N. C. Gorin and J. M. Bertho, Plasma Flt-3 ligand concentration correlated with radiation-induced bone marrow damage during local fractionated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 57, 508-515 (2003).
19. E. Chklovskaia, C. Nissen, L. Landmann, C. Rahner, O. Pfister and A. Wodnar-Filipowicz, Cell-surface trafficking and release of Flt3 ligand from T lymphocytes is induced by common cytokine receptor γ-chain signaling and is inhibited by cyclosporin A. Blood 97, 1027-1034 (2001).
20. J. H. Hendry and Y. Feng-Tong, Response of bone marrow to low LET irradiation. In Radiation Toxicology, Bone Marrow and Leukemia (J. H. Hendry and B. I. Lord, Ed.), pp. 91-116. CRC Press, London, 1995.
21. J. Dutreix, T. Girinski, J. M. Cosset, A. Bernard, J. Pico, D. Baume, C. Bayle and V. Benk, Blood cell kinetics and total body irradiation. Radiother. Oncol. 9, 119-129 (1987).
22. R. E. Anderson, G. B. Olson, J. R. Autry, J. L. Howarth, G. M. Troup and P. H. Bartels, Radiosensitivity of T and B lymphocytes. IV. Effect of whole body irradiation upon various lymphoid tissues and numbers of recirculating lymphocytes. J. Immunol. 118, 1191-1200 (1977).
23. A. Ropenga, A. Chapel, M. Vandamme and N. M. Griffiths, Use of reference gene expression in rat distal colon after radiation exposure: A caveat. Radiat. Res. 161, 597-602 (2004).
24. M. Hott and P. J. Marie, Glycol methacrylate as an embedding medium for bone. Stain. Technol. 62, 51-57 (1987).
25. C. S. Potten, A comprehensive study of the radiobiological response of the murine (BDF1) small intestine. Int. J. Radiat. Biol. 58, 925-973 (1990).
26. S. Fichelson, The Flt3/Flk2 ligand: Structure, functions and prospects. Eur. Cytokine Netw. 9, 7-22 (2000).
27. W. Matthews, C. T. Jordan, G. W. Wiegand, D. Pardoll and I. R. Lemischka, A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched population. Cell 65, 1143-1152 (1991).
28. O. Rosnet, C. Schiff, M. J. Pébusque, S. Marchetto, C. Tonnelle, Y. Toiron, F. Birq and D. Birnbaum, Human Flt3/Flk2 gene: cDNA cloning and expression in hematopoietic cells. Blood 82, 1110-1119 (1993).
29. + dendritic cells in vivo. J. Exp. Med. 198, 305-313 (2003).
30. T. McClanahan, J. Culpper, D. Campell, J. Wagner, K. Franz-Bacon, J. Mattson, S. Tsai, J. Luh, M. Guimaraes and C. Hannum, Biochemical and genetic characterization of multiple splice variants of Flt3 ligand. Blood 9, 3371-3382 (1996).
31. S. Hudak, M. W. Leach, Y. Xu, S. Menon and D. Rennick, Radioprotective effects of flk2/flt3 ligand. Exp. Hematol. 26, 515-522 (1998).
32. A. Solanilla, J. Dechanet, A. Andaloussi, M. Dupouy, F. Godard, J. Chabrol, J. Reiffers, A. Nurden, B. Weksler and J. Ripoche, CD40-ligand stimulates myelopoieses by regulation Flt3 ligand and thrombopoietin production in bone marrow stromal cells. Blood 95, 3758-3764 (2000).
33. K. A. Moore, Recent advances in defining the hematopoietic stem cell niche. Curr. Opin. Hematol. 11, 17-111 (2004).
34. T. J. Fry and C. L. Mackall, Interleukin-7: Master regulator of peripheral T-cell homeostasis? Trends Immunol. 22, 564-571 (2001).
35. S. P. Dormady, O. Bashayan, R. Dougherty, X. M. Zhang and R. S. Basch, Immortalized mesenchymal cells and the hematopoietic microenvironment. J. Hematother. Stem Cell Res. 10, 125-140 (2001).
36. + PBSC in patients undergoing high-dose chemotherapy and stem cell rescue. J. Hematother. Stem Cell Res. 9, 285-293 (2000).